Brooklyn Immunotherapeutics Inc (NASDAQ:BTX)

9.03
Delayed Data
As of Oct 22
 -0.59 / -6.13%
Today’s Change
3.50
Today|||52-Week Range
80.67
+101.56%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Brooklyn Immunotherapeutics Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median estimate represents a +121.48% increase from the last price of 9.03.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Brooklyn Immunotherapeutics Inc. This rating has held steady since October, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.08
Sales
--
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 66.67%
 
 
 
 
 
 
Growthannually 37.50%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
Growthannually 468.61%
 
 
 
 
 
Key to the earnings and sales forecast charts.